(IN BRIEF) Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed motor progression narrowly missed statistical significance, promising efficacy trends were observed, … Read the full press release
(IN BRIEF) BASF has introduced Symbiocell®, a new cosmetic ingredient derived from Cestrum latifolium leaves, now approved for use in China following a successful regulatory notification. Designed to soothe sensitive skin and reduce excessive skin reactions, Symbiocell® has shown strong … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Security & Safety, Technology
Tagged BASF, CHINA, INNOVATION, partnership, safety, Sensitive Skin, sustainability, Symbiocell®
(IN BRIEF) The FDA has granted Breakthrough Therapy designation to tolebrutinib for treating adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS), following positive results from the HERCULES phase 3 study. The study showed tolebrutinib delayed disability progression by 31% and … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Dr. Erik Wallström, FDA, Progressive Multiple Sclerosis, safety, Sanofi, tolebrutinib
(IN BRIEF) Roche has received CE certification for its enhanced cobas® 6800/8800 systems 2.0, introducing significant improvements in laboratory diagnostics. The upgrade streamlines operations by reducing downtime, consolidating test menus, and increasing throughput, supported by innovative TAGS technology that detects … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged cobas Systems 2.0, Matt Sause, Molecular Diagnostics, Roche, safety
(IN BRIEF) Roche’s Vabysmo® (faricimab) prefilled syringe has received European Medicines Agency approval for treating three major retinal conditions: neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema caused by retinal vein occlusion (RVO). Serving over nine … Read the full press release
(IN BRIEF) Volvo Autonomous Solutions (V.A.S.) and DHL Supply Chain have joined forces to revolutionize freight transportation in the U.S. using the production-ready Volvo VNL Autonomous, powered by Aurora Driver technology. The partnership aims to validate the ecosystem required for … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Security & Safety, Sweden, Technology, Transportation & Logistics
Tagged Autonomous Freight Operations, DHL, Jim Monkmeyer, logistics, Nils Jaeger, partnership, safety, Sasko Cuklev, sustainability, U.S., Volvo
(IN BRIEF) DNV has released the DNV-ST-J301 Electrolyser Systems standard, setting a benchmark for the safe design, construction, and operation of electrolysers used in hydrogen production. This standard provides a comprehensive, risk-based framework to ensure safety and scalability throughout the … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Industrial, Infrastructure & Utilities, Investment, Management, News, Norway, Security & Safety, Technology
Tagged DNV, DNV-ST-J301 Electrolyser Systems Standard, Electrolyser Systems, hydrogen production, Magnus Killingland, Peter Paschke, Prajeev Rasiah, safety, Scalability
(IN BRIEF) SGS has partnered with ENSESO4Food to integrate the Trakkey4Food platform into SGS’s compliance services for the US FDA’s FSMA 204 traceability rule. This collaboration aims to improve food traceability, safety, and transparency across the supply chain. Trakkey4Food offers … Read the full press release
Posted in Business, Environment, Financial, Food & Beverage, Government, Industrial, Investment, Management, News, Security & Safety, Switzerland, Technology
Tagged digital platform, ENSESO4Food, Food Traceability, INNOVATION, John Moss, Naghmeh Raiyat, partnership, safety, SGS, sustainability, transparency, USA
(IN BRIEF) Roche presented new data at the ASH 2024 meeting highlighting the effectiveness of its bispecific antibodies, Columvi and Lunsumio, in treating lymphomas. Long-term studies show durable remissions and immune system recovery with fixed-duration therapies, while real-world data emphasize … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged ASH 2024, Bispecific Antibodies, Columvi, Levi Garraway, Lunsumio, Lymphoma Treatment, Roche, safety
(IN BRIEF) Thales and Avinor have partnered to implement a next-generation Unmanned Traffic Management (UTM) system across Norway, enabling the safe integration of unmanned and manned aircraft while adhering to European regulatory standards. Powered by Thales’ TopSky – UAS and … Read the full press release
Posted in Aviation & Aerospace, Business, Environment, Financial, France, Government, Industrial, Investment, Management, News, Norway, Security & Safety, Technology, Transportation & Logistics
Tagged Avinor, Christian Rivierre, INNOVATION, Mats Bye Gjertsen, Norway, partnership, safety, sustainability, Thales, Unmanned Traffic Management System
(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP). Scemblix achieved significantly higher major … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged 96-week results, asciminib, ASH Annual Meeting, chronic myeloid leukemia, CML care, discontinuation rate, imatinib, major molecular response, MMR, National Comprehensive Cancer Network, NCCN, newly diagnosed settings, Novartis, oncology, Ph+ CML-CP, Phase II ASC2ESCALATE trial, Phase III ASC4FIRST trial, Philadelphia chromosome-positive chronic myeloid leukemia, safety, Scemblix, Second-Line Treatment, severe adverse events, standard-of-care, TKIs, tolerability, tyrosine kinase inhibitors
(IN BRIEF) AstraZeneca’s Imfinzi (durvalumab) has been granted Priority Review by the FDA for the treatment of muscle-invasive bladder cancer (MIBC), potentially becoming the first perioperative immunotherapy in this curative-intent setting. Supported by results from the NIAGARA Phase III trial, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, bladder cancer, FDA, Imfinzi, Perioperative Immunotherapy, safety, Susan Galbraith
(IN BRIEF) Sampo plc has donated €50,000 to the Finnish Red Cross Disaster Relief Fund to support global humanitarian aid for those affected by natural disasters and conflicts. The fund provides essentials like food, water, shelter, and field hospitals, while … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Finland, Government, Industrial, Insurance, Investment, Management, News
Tagged donation, Finnish Red Cross Disaster Relief Fund, health, Johanna Tynkkynen, partnership, Red Cross, safety, Sampo, Sirpa Solehmainen, sustainability, well-being
(IN BRIEF) The European Commission has approved Theralugand®, Eckert & Ziegler’s high-purity Lutetium-177 chloride, for routine clinical use across the European Economic Area. This approval allows its application in targeted cancer therapies, such as for neuroendocrine tumors and metastatic prostate … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Cancer Therapies, Dr. Harald Hasselmann, Eckert & Ziegler, EU, Healthcare, safety, Theralugand®, wellness
(IN BRIEF) Boehringer Ingelheim has launched VETMEDIN® Solution, the first FDA-approved liquid treatment for congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). The solution provides a convenient, twice-daily alternative to tablets, … Read the full press release
(IN BRIEF) Novartis has secured European Commission approval for Kisqali® (ribociclib) in combination with endocrine therapy (ET) as an adjuvant treatment for high-risk hormone receptor-positive (HR+), HER2-negative early breast cancer (EBC). The approval, based on the Phase III NATALEE trial, … Read the full press release
(IN BRIEF) Roche provided an update on its Phase III SKYSCRAPER-01 study, evaluating tiragolumab in combination with Tecentriq® for patients with PD-L1-high, advanced, or metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of improving … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Lung Cancer Therapy, Roche, safety, SKYSCRAPER-01 Study, TECENTRIQ, Tiragolumab
(IN BRIEF) Continental has introduced ATE SecuBrake, the first sustainably produced DOT 4 brake fluid free from hazardous materials requiring special labelling. Part of the ATE New Original line, it is designed for advanced braking systems, including those in electric … Read the full press release
(IN BRIEF) Experian is warning consumers and businesses to protect personal information during the Christmas season, as identity fraud spikes amid increased spending. New data shows fraud rates in the last quarter of the year have risen by 21% over … Read the full press release
Posted in Business, Economy, Financial, Government, Industrial, Internet & Online, Investment, Management, News, Security & Safety, Technology, United Kingdom
Tagged Christmas season, Experian, holidays, identity fraud, Paul Weathersby, safety, tips
(IN BRIEF) VINCI Highways has launched its winter operations program to ensure safe and accessible roads during challenging weather conditions. With a fleet of snowploughs, salt spreaders, and brine sprayers ready, along with strategic salt reserves, trained teams are on … Read the full press release
Posted in Berlin, Business, Financial, France, Industrial, Infrastructure & Utilities, Investment, Management, News, Security & Safety, Technology
Tagged Accessible Roads, holiday season, safety, VINCI Highways, Winter Operations
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?